Keywords: عامل رشد فیبروبلاست 19; Fibroblast growth factor 19 (FGF19); Mitochondrial energy homoeostasis; Diabetic cardiomyopathy (DCM); PGC-1α; Fibroblast growth factor 19; (FGF19); peroxisome proliferator-activated receptor-γ coactivator; (PGC-1α); Diabetic cardiomyopathy; (DCM); str
مقالات ISI عامل رشد فیبروبلاست 19 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل رشد فیبروبلاست 19; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; FC; free cholesterol; VLDL; very low density lipoprotein; LDL; low density lipoprotein; mTOR; mechanistic target of rapamycin signaling; AMPK; AMP-activated protein kinase; TG; t
Keywords: عامل رشد فیبروبلاست 19; ATP; Adenosine 5c-triphosphate; ALT; Alanine aminotransferase; aa; Amino acid; ASK1; Apoptosis signal- regulating kinase 1; AST; Aspartate aminotransferase; BASH; Both alcoholic and non-alcoholic liver disease; CCR2/CCR5; C-C chemokine receptor types 2 an
Keywords: عامل رشد فیبروبلاست 19; Cholic Acid; Chenodeoxycholic Acid; 7α-Hydroxy-4-Cholesten-3-One; GPBAR1 (G-Protein-Coupled Bile Acid Receptor 1); BA; bile acid; BAM; bile acid malabsorption; C4; 7α-hydroxy-4-cholesten-3-one; CDCA; chenodeoxycholic acid; DCA; deoxycholic acid; FGF19
Keywords: عامل رشد فیبروبلاست 19; Fibroblast growth factor 19; Visceral fat accumulation; Glucose tolerance status; ANCOVA; analysis of covariance; ANOVA; One-way analysis of variance; BA; bile acid; BMI; body mass index; DBP; diastolic blood pressure; DM; diabetes mellitus; FFM; free fat
Keywords: عامل رشد فیبروبلاست 19; Fibroblast growth factor 19; Diabetes; Oral glucose loading; Coronary angiography; Abnormal glucose regulation; Age;
Keywords: عامل رشد فیبروبلاست 19; IF; intestinal failure; PN; parenteral nutrition; IFALD; intestinal failure associated liver disease; IL-6; interleukin-6; TNF-α; tumor necrosis factor-α; FGF19; fibroblast growth factor 19; FXR; farnesoid nuclear receptor X; NAFLD; nonalcoholic fatty l
Discovery and optimization of selective FGFR4 inhibitors via scaffold hopping
Keywords: عامل رشد فیبروبلاست 19; Hepatocellular carcinoma; Fibroblast growth factor 19; Fibroblast growth factor receptor 4; Covalent inhibitor; Isoform selective;
Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A
Keywords: عامل رشد فیبروبلاست 19; Fibroblast growth factor 19; Farnesoid X receptor; Bile acid; Nuclear receptor; Vitamin A; Retinoic acid
Original articleLong-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot study
Keywords: عامل رشد فیبروبلاست 19; Triglyceride-rich lipoproteins; Apoprotein B48; Gut hormones; Bile acids; Fibroblast growth factor 19; Bariatric surgery; RYGB; Roux-en-Y-gastric bypass; TG; triglycerides; ApoB; apolipoprotein B; VLDL; very low density lipoprotein; C4; 7-alpha hydroxy 4-
SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells
Keywords: عامل رشد فیبروبلاست 19; ChIP; chromatin immunoprecipitation; DR-1; direct repeat separated by 1 nucleotide; EMSA; electrophoretic mobility shift assay; ER-8; everted repeat separated by 8 nucleotides; FXR; farnesoid X receptor; FGF19; fibroblast growth factor 19; GST; glutathion
Research ArticleAltered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease
Keywords: عامل رشد فیبروبلاست 19; SBS; short bowel syndrome; SBS-ALD; short bowel syndrome-associated liver disease; PN; parenteral nutrition; SBR; small bowel resection; BA; bile acid; FXR; farnesoid X receptor; SHP; small heterodimer partner; FGF19; fibroblast growth factor 19; CYP7A1;
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
Keywords: عامل رشد فیبروبلاست 19; Fibroblast growth factor 19; Nonalcoholic fatty liver disease; Hepatocyte ballooning; Enzyme-linked immunosorbent assay
Farnesoid X Receptor Protects Hepatocytes From Injury by Repressing miR-199a-3p, Which Increases Levels of LKB1
Keywords: عامل رشد فیبروبلاست 19; Nuclear Receptor; Noncoding RNA; Mitochondrial Protection; Fibrotic Liver Injury; AA; arachidonic acid; AMPK; AMP-activated protein kinase; ASO; antisense oligonucleotide; CAB39; calcium binding protein 39; CDCA; chenodeoxycholic acid; DCFH-DA; 2â²,7â²-
Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis
Keywords: عامل رشد فیبروبلاست 19; Bile Acid; 7αC4; FGF19; FGFR4; AC; ascending; ANCOVA; analysis of covariance; BMI; body mass index; CDC; (sodium) chenodeoxycholate; CF6; colonic filling at 6 hours; FGF19; fibroblast growth factor 19; FGFR4; fibroblast growth factor receptor 4; GC; geom
A New Mechanism for Bile Acid Diarrhea: Defective Feedback Inhibition of Bile Acid Biosynthesis
Keywords: عامل رشد فیبروبلاست 19; ASBT; apical sodium-dependent bile acid transporter; BA; bile acid; BAM; bile acid malabsorption; C4; 7α-hydroxy-4-cholesten-3-one; CYP7A1; cholesterol 7α hydroxylase; ELISA; enzyme-linked immunosorbent assay; FGFR4; fibroblast growth receptor 4; FGF15;
Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
Keywords: عامل رشد فیبروبلاست 19; AFP; alpha-fetoprotein; ANOVA; analysis of variance; ELISA; enzyme-linked immunosorbent assay; FGF19; fibroblast growth factor 19; FGFR; fibroblast growth factor receptor; FRS2α; FGFR substrate protein-2α; GAPDH; glyceraldehyde 3-phosphate dehydrogenase